Rietavo veterinarinė sanitarija, UAB - financials and debts
Company age: 35 y. 9 mo.
Rietavo veterinarinė sanitarija - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 11,575,338 | 10,878,081 | 9,818,998 | 14,256,237 | 18,651,616 | 15,638,181 | 15,422,071 | 19,618,625 |
| Profit before tax | -557,913 | -762,892 | -9,468,123 | 214,516 | -5,397,771 | 9,248,888 | 105,261 | 1,723,386 |
| Net profit | -567,816 | -762,513 | -9,604,378 | 214,544 | -5,184,753 | 9,214,127 | 209,778 | 1,465,464 |
| Equity | 2,521,469 | 1,758,956 | -7,845,422 | -7,560,961 | -12,557,382 | 932,903 | 923,315 | 2,388,778 |
| Liabilities | 19,072,390 | 17,564,070 | 16,920,979 | 18,176,989 | 19,548,165 | 8,502,864 | 9,656,364 | 8,439,795 |
| Non-current assets | 8,114,168 | 5,469,120 | 4,177,911 | 4,623,155 | 5,653,725 | 8,066,817 | 6,937,011 | 8,383,798 |
| Current assets | 13,648,943 | 13,964,985 | 4,999,436 | 6,021,659 | 1,387,536 | 2,054,596 | 4,182,473 | 2,781,599 |
| Total assets | 21,763,111 | 19,434,105 | 9,177,347 | 10,644,814 | 7,041,261 | 10,121,413 | 11,119,484 | 11,165,397 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 327,501 | 405,809 | - |
| Social insurance contributions | - | - | - | - | - | 580,273 | 498,080 | 506,105 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -13.5% | -6.0% | -9.7% | +45.2% | +30.8% | -16.2% | -1.4% | +27.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -2.6% | -3.9% | -104.7% | 2.0% | -73.6% | 91.0% | 1.9% | 13.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -22.5% | -43.4% | - | - | - | 987.7% | 22.7% | 61.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -4.9% | -7.0% | -97.8% | 1.5% | -27.8% | 58.9% | 1.4% | 7.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -4.8% | -7.0% | -96.4% | 1.5% | -28.9% | 59.1% | 0.7% | 8.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 7.6 | 10.0 | - | - | - | 9.1 | 10.5 | 3.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 94,750 | 87,316 | 77,315 | 144,733 | 192,948 | 158,495 | 189,228 | 258,707 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Rietavo veterinarinė sanitarija - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-11-18 | 2024-12-12 | 4253.29 |
| 2024-10-16 | 2024-11-11 | 8956.02 |
| 2024-09-17 | 2024-10-14 | 13658.75 |
| 2024-08-19 | 2024-09-12 | 18361.48 |
| 2024-07-16 | 2024-08-12 | 23064.21 |
| 2024-06-18 | 2024-07-11 | 27766.94 |
| 2024-05-16 | 2024-06-13 | 32453.95 |
| 2024-04-16 | 2024-05-13 | 37156.68 |
| 2024-03-18 | 2024-04-11 | 41838.99 |
| 2024-02-19 | 2024-03-14 | 46521.30 |
| 2024-01-16 | 2024-02-14 | 51224.03 |
| 2024-01-15 | 2024-01-15 | 3605.93 |
| 2024-01-05 | 2024-01-11 | 55926.76 |
| 2023-12-18 | 2024-01-04 | 55933.35 |
| 2023-12-15 | 2023-12-17 | 7117.90 |
| 2023-11-21 | 2023-12-14 | 60636.08 |
| 2023-11-16 | 2023-11-20 | 60635.49 |
| 2023-11-15 | 2023-11-15 | 12814.80 |
| 2023-10-17 | 2023-11-14 | 65338.22 |
| 2023-10-13 | 2023-10-16 | 17320.05 |
| 2023-09-21 | 2023-10-12 | 70040.95 |
| 2023-09-20 | 2023-09-20 | 70074.65 |
| 2023-09-18 | 2023-09-19 | 70574.65 |
| 2023-09-15 | 2023-09-17 | 17468.12 |
| 2023-08-17 | 2023-09-14 | 75243.74 |
| 2023-08-14 | 2023-08-16 | 19481.67 |
| 2023-07-31 | 2023-08-13 | 75243.74 |
| 2023-07-18 | 2023-07-30 | 75390.15 |
| 2023-07-14 | 2023-07-17 | 26328.58 |
| 2023-06-16 | 2023-07-13 | 75243.74 |
| 2023-02-11 | 2023-02-12 | 19.29 |
| 2022-12-16 | 2022-12-19 | 13.15 |
| 2022-12-14 | 2022-12-15 | 13.14 |
| 2022-10-18 | 2022-10-20 | 0.06 |
| 2022-09-12 | 2022-09-22 | 0.07 |
| 2022-08-23 | 2022-09-11 | 350522.47 |
| 2022-08-16 | 2022-08-22 | 306676.97 |
| 2022-08-03 | 2022-08-15 | 350522.47 |
| 2022-07-18 | 2022-08-02 | 350522.40 |
| 2022-07-15 | 2022-07-17 | 310397.10 |
| 2022-06-27 | 2022-07-14 | 350522.40 |
| 2022-06-17 | 2022-06-26 | 350516.32 |
| 2022-06-16 | 2022-06-16 | 350640.51 |
| 2022-06-14 | 2022-06-15 | 308746.07 |
| 2022-05-17 | 2022-06-13 | 350522.41 |
| 2022-05-13 | 2022-05-16 | 310475.34 |
| 2022-04-19 | 2022-05-12 | 350522.41 |
| 2022-04-15 | 2022-04-18 | 309964.96 |
| 2022-03-28 | 2022-04-14 | 350916.75 |
| 2022-03-16 | 2022-03-27 | 350522.41 |
| 2022-03-15 | 2022-03-15 | 314164.81 |
| 2022-02-17 | 2022-03-14 | 350522.41 |
| 2022-02-15 | 2022-02-16 | 311407.72 |
| 2022-02-11 | 2022-02-14 | 350514.82 |
| 2022-01-28 | 2022-02-10 | 350522.41 |
| 2022-01-26 | 2022-01-27 | 350657.26 |
| 2022-01-18 | 2022-01-25 | 350273.95 |
| 2022-01-14 | 2022-01-17 | 309573.17 |
| 2021-12-17 | 2022-01-13 | 350522.41 |
| 2021-12-16 | 2021-12-16 | 350522.40 |
| 2021-12-14 | 2021-12-15 | 309351.06 |
| 2021-10-18 | 2021-12-13 | 350522.40 |
| 2021-10-15 | 2021-10-17 | 313639.81 |
| 2021-10-01 | 2021-10-14 | 350498.93 |
| 2021-09-29 | 2021-09-30 | 351201.47 |
| 2021-09-16 | 2021-09-28 | 350498.93 |
Rietavo veterinarinė sanitarija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-05-19 | 2026-05-20 | 2.44 |
| 2026-05-15 | 2026-05-18 | 508.0 |
| 2026-05-13 | 2026-05-14 | 452.95 |
| 2025-03-20 | 2025-03-24 | 0.65 |
| 2024-11-20 | 2024-11-23 | 0.44 |
| 2024-11-17 | 2024-11-19 | 472.38 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Rietavo veterinarine sanitarija, UAB (code 169704164) is a Private Limited Liability Company operating in manufacture of oils and fats. In 2025, revenue increased to €19.62M from €15.42M in 2024, up 27.2% year on year and 25.4% over two years. Net profit rose to €1.47M from €209.8K in 2024, with a profit margin of 7.5%, after a much weaker 1.4% margin in 2024 and a very strong 2023 result of €9.21M on €15.64M revenue. Total assets were €11.17M at the end of 2025, close to €11.12M in 2024, while equity increased to €2.39M from €923.3K. Liabilities remained significant at €8.44M, but lower than €9.66M in 2024. Key indicators for 2025 show ROE of 61.4%, ROA of 13.1%, debt-to-equity of 3.53, and asset turnover of 1.76x. With revenue per employee at €261.6K and profit per employee at €19.5K, the company showed stronger profitability and a solid rebound in 2025.